Newleos secures $93.5m for neuropsychiatric treatments
Pharmaceutical Technology
FEBRUARY 14, 2025
Newleos has closed an oversubscribed Series A financing round, raising $93.5m to revolutionise neuropsychiatric disorder treatments.
Fri.Feb 14, 2025
179 
‘It’s not for the faint of heart.’ How 3 CEOs took their biotechs public
Bio Pharma Dive
FEBRUARY 14, 2025
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public in a challenging market for biotech stocks.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
EU reshapes HTAs: is the industry ready for it?
Pharmaceutical Technology
FEBRUARY 14, 2025
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes
Medical Xpress
FEBRUARY 14, 2025
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
DMD market expected to grow to $5.2bn in the 7MM by 2033
Pharmaceutical Technology
FEBRUARY 14, 2025
The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, the UK, and Japan - is projected to experience significant growth, with sales increasing from $2.3bn in 2023 to $5.2bn by 2033, according to leading data and analytics company GlobalData.
Study explains how antidepressants can protect against infections and sepsis
Medical Xpress
FEBRUARY 14, 2025
Antidepressants like Prozac are commonly prescribed to treat mental health disorders, but new research suggests they could also protect against serious infections and life-threatening sepsis.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Eye told you so: Why illusions are all in the eye of the beholder
Medical Xpress
FEBRUARY 14, 2025
Our brain and eyes can play tricks on usnot least when it comes to the expanding hole illusion. A new computational model developed by Flinders University experts helps to explain how cells in the human retina make us "see" the dark central region of a black hole graphic expand outwards.
Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia
Pharmaceutical Technology
FEBRUARY 14, 2025
Health Canada has approved Novartis Canadas Fabhalta (iptacopan capsules) as the first oral monotherapy to treat adults with PNH.
New drug delivery method promises long-lasting glaucoma relief
Medical Xpress
FEBRUARY 14, 2025
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily eye drops to treat glaucoma, a leading cause of blindness.
RFK Jr-led commission will assess 'threats' to children
pharmaphorum
FEBRUARY 14, 2025
New HHS Secretary RFK Fr has been given the task of investigating child health in the US, including whether some medicines may pose a threat.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
'Gut-on-chip' can predict immunotherapy outcomes for melanoma patients
Medical Xpress
FEBRUARY 14, 2025
A team of researchers has developed a "gut-on-chip" (a miniature model of the human intestine on a chip-sized device) capable of reproducing the main features of intestinal inflammation and of predicting the response of melanoma patients to immunotherapy treatment. The results have just been published in Nature Biomedical Engineering.
Apple study will look at the role tech can play in health
pharmaphorum
FEBRUARY 14, 2025
Apple has started a major new health study to see how devices like the iPhone, Apple Watch, and AirPods can be used to monitor and improve our health.
New gene switch activates with simple skin patch and could help treat diabetes
Medical Xpress
FEBRUARY 14, 2025
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind to trigger cell therapies for various metabolic diseases.
EU approves CSL's once-monthly HAE drug Andembry
pharmaphorum
FEBRUARY 14, 2025
The EU has approved CSL's once-monthly Andembry for hereditary angioedema, challenging therapies from Takeda and Biocryst
Leg muscle may serve as an early warning system for heart failure, study finds
Medical Xpress
FEBRUARY 14, 2025
Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg muscles may help detect cardiovascular disease earlier than standardized tests, opening the door to earlier treatment and better outcomes.
BMS study of Opdualag in adjuvant melanoma ends in failure
pharmaphorum
FEBRUARY 14, 2025
Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in an adjuvant melanoma study.
Most adults don't trust health care to use AI responsibly and without harm, survey finds
Medical Xpress
FEBRUARY 14, 2025
A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care systems to make sure an AI tool would not harm them.
Taking the quantum leap: How life science real estate clusters accelerate innovation
pharmaphorum
FEBRUARY 14, 2025
Discover how life science real estate clusters drive innovation and collaboration, leading to groundbreaking advancements in the industry. Explore the impact of these clusters and how they propel progress in life sciences.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Too few women who pause breast cancer treatment during pregnancy resume therapy after delivery
Medical Xpress
FEBRUARY 14, 2025
Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the medications can't be taken during pregnancy or while breastfeeding; premenopausal women wishing to start or grow their families must pause the treatment for months or years.
Pharma digitalisation and transformation of HCP engagement with KAMs
pharmaphorum
FEBRUARY 14, 2025
Watch the video interview featuring Chris Moore, President Europe at Veeva, and Nicole Raleigh, Web Editor at pharmaphorum, as they discuss industry trends and insights.
A mitochondrial protein's protective role offers new hope for Charcot-Marie-Tooth disease
Medical Xpress
FEBRUARY 14, 2025
Researchers from Cologne, Bochum, Padova and Angers have discovered a novel connection between mitochondrial function, protein quality control and cellular health, whose failure could be the leading cause of the currently incurable neurological disease Charcot-Marie-Tooth (CMT).
Axplora Invests $52.5 Million into GLP-1 Manufacturing Facility
Pharmaceutical Commerce
FEBRUARY 14, 2025
The companys Mourenx plant in Southwest France aims to become an API network hub, with first supplies expected by next year.
Analysis system enhances rapid pathogen detection with CRISPR technology
Medical Xpress
FEBRUARY 14, 2025
A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a point-of-care testing (POCT) system based on microfluidic CRISPR-Dx technology, significantly improving the sensitivity, speed, and multiplexing capability of pathogen detection.
How HCPs and Patients Influence the CGT Approval Process
Pharmaceutical Commerce
FEBRUARY 14, 2025
In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, describes why these pharma supply chain stakeholders are vital in understanding meaningful clinical outcomes.
Brain bleeds double later-life dementia risk, study finds
Medical Xpress
FEBRUARY 14, 2025
Weill Cornell Medicine researchers have found that intracranial hemorrhages, or "brain bleeds," caused by a ruptured blood vessel in the brain, double a person's risk of developing dementia later in life.
Pharma Pulse 2/14/25: RFK Jr. Confirmed as HHS Secretary, How Pharma Can Effectively Combat Misinformation & more
Pharmaceutical Commerce
FEBRUARY 14, 2025
The latest news for pharma industry insiders.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
New blood test could improve Alzheimer's disease diagnosis, research finds
Medical Xpress
FEBRUARY 14, 2025
Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the potential to transform patient care, allowing for better diagnosis, earlier interventions and more targeted treatments.
First self-amplifying mRNA vaccine reaches Europe
pharmaphorum
FEBRUARY 14, 2025
Arcturus Therapeutics and CSL's COVID-19 vaccine Kostaive is the first in the new sa-mRNA class to be approved for marketing in the EU
Is this the new 5:2 diet? Eating more plant-based meals could boost longevity
Medical Xpress
FEBRUARY 14, 2025
A new book by Professor Luigi Fontana with recipes from Healthy Longevity Chef Marzio Lanzini at the University of Sydney's Charles Perkins Center (CPC) has set out a medical science-backed plan for eating more plant-based meals to enhance overall health and longevity.
EC approves CSL’s Andembry to stop hereditary angioedema attacks
Pharmaceutical Technology
FEBRUARY 14, 2025
CSL has received approval from the EC for Andembry (garadacimab) to prevent recurrent attacks of HAE in patients aged 12 years and above.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content